pirfenidone has been researched along with Allergic Alveolitis, Extrinsic in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 5 (55.56) | 24.3611 |
2020's | 4 (44.44) | 2.80 |
Authors | Studies |
---|---|
Crooks, JL; Fernández Pérez, ER; Fier, K; Groshong, SD; Humphries, SM; Koelsch, TL; Lynch, DA; Mohning, MP; Solomon, JJ; Swigris, JJ | 1 |
Abdelmoneim, AM; Alanazi, MM; Baioumy, B; El-Shafey, RS; Elshazly, AME; Faruk, EM; Hussein, AYA; Mersal, EA; Mogahed, MM; Morsi, AA | 1 |
Assayag, D; Chaudhuri, N | 1 |
Buendía-Roldan, I; Castillo-Castillo, K; Castillo-Pedroza, J; Estrada, A; Gaxiola, M; Mateos-Toledo, H; Mejía-Ávila, M; Mejía-Hurtado, JG; Rodríguez-Barreto, Ó; Rojas-Serrano, J; Selman, M | 1 |
Leslie, K; Morell, F; Raghu, G; Vasakova, M; Walsh, S | 1 |
Behr, J; Günther, A; Kreuter, M; Neuser, P; Prasse, A; Rabe, K; Schade-Brittinger, C; Wagner, J | 1 |
Black, KE; Feneis, JF; Mark, EJ; Montesi, SB | 1 |
Adegunsoye, A; Strek, ME | 1 |
Luckhardt, TR; Müller-Quernheim, J; Thannickal, VJ | 1 |
2 review(s) available for pirfenidone and Allergic Alveolitis, Extrinsic
Article | Year |
---|---|
Therapeutic Approach to Adult Fibrotic Lung Diseases.
Topics: Alveolitis, Extrinsic Allergic; Anti-Inflammatory Agents, Non-Steroidal; Connective Tissue Diseases; Disease Progression; Enzyme Inhibitors; Humans; Idiopathic Pulmonary Fibrosis; Immunosuppressive Agents; Indoles; Lung Diseases, Interstitial; Prognosis; Pyridones | 2016 |
Update in diffuse parenchymal lung disease 2011.
Topics: Alveolitis, Extrinsic Allergic; Anti-Inflammatory Agents, Non-Steroidal; Autoimmunity; Clinical Trials as Topic; Comorbidity; Gastroesophageal Reflux; Homeostasis; Humans; Lung Diseases, Interstitial; Pyridones; Risk Assessment; Sarcoidosis, Pulmonary | 2012 |
3 trial(s) available for pirfenidone and Allergic Alveolitis, Extrinsic
Article | Year |
---|---|
Pirfenidone in fibrotic hypersensitivity pneumonitis: a double-blind, randomised clinical trial of efficacy and safety.
Topics: Adult; Alveolitis, Extrinsic Allergic; COVID-19; Disease Progression; Double-Blind Method; Humans; Idiopathic Pulmonary Fibrosis; Pandemics; Pyridones; Treatment Outcome; Vital Capacity | 2023 |
An Open-label Study With Pirfenidone on Chronic Hypersensitivity Pneumonitis.
Topics: Adult; Alveolitis, Extrinsic Allergic; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Carbon Monoxide; Double-Blind Method; Female; Humans; Idiopathic Pulmonary Fibrosis; Immunosuppressive Agents; Lung; Male; Middle Aged; Prednisone; Prospective Studies; Pyridones; Quality of Life; Treatment Outcome; Vital Capacity | 2020 |
Exploring efficacy and safety of oral Pirfenidone for progressive, non-IPF lung fibrosis (RELIEF) - a randomized, double-blind, placebo-controlled, parallel group, multi-center, phase II trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alveolitis, Extrinsic Allergic; Anti-Inflammatory Agents, Non-Steroidal; Connective Tissue Diseases; Disease Progression; Double-Blind Method; Female; Humans; Lung; Male; Middle Aged; Pulmonary Fibrosis; Pyridones; Research Design; Treatment Outcome; Vital Capacity; Young Adult | 2017 |
4 other study(ies) available for pirfenidone and Allergic Alveolitis, Extrinsic
Article | Year |
---|---|
Modeling the Effects of Cypermethrin Toxicity on Ovalbumin-Induced Allergic Pneumonitis Rats: Macrophage Phenotype Differentiation and p38/STAT6 Signaling Are Candidate Targets of Pirfenidone Treatment.
Topics: Alveolitis, Extrinsic Allergic; Animals; Asthma; Dexamethasone; Inflammation; Macrophages; Male; Ovalbumin; p38 Mitogen-Activated Protein Kinases; Phenotype; Pneumonia; Rats; Rats, Wistar | 2023 |
Pirfenidone in fibrotic hypersensitivity pneumonitis: is it ready for prime time?
Topics: Alveolitis, Extrinsic Allergic; Humans; Lung; Pyridones | 2023 |
Hypersensitivity Pneumonitis: Perspectives in Diagnosis and Management.
Topics: Acute Disease; Adrenal Cortex Hormones; Alveolitis, Extrinsic Allergic; Anti-Inflammatory Agents, Non-Steroidal; Antigens; Bronchoalveolar Lavage Fluid; Chronic Disease; Disease Progression; Enzyme Inhibitors; Humans; Immunoglobulin G; Immunologic Factors; Immunosuppressive Agents; Indoles; Lung; Lung Transplantation; Pyridones; Tomography, X-Ray Computed | 2017 |
Case 10-2019: A 69-Year-Old Man with Progressive Dyspnea.
Topics: Aged; Alveolitis, Extrinsic Allergic; Biopsy; Diagnosis, Differential; Dyspnea; Humans; Idiopathic Pulmonary Fibrosis; Indoles; Lung; Male; Pyridones; Radiography, Thoracic; Sarcoidosis; Tomography, X-Ray Computed | 2019 |